LEXEO THERAPEUTICS IN
8.9000
08-10月-24 10:37:15
15 分の遅延
株式
+0.3800
+4.46%
本日の幅
8.4550 - 8.9000
ISIN
N/A
ソース
NASDAQ
-
Lexeo Therapeutics to Participate in Upcoming Investor Conferences
05 9 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
Lexeo Therapeutics Reports Second Quarter 2024 Financial Results and Operational Highlights
12 8 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
15 7 2024 06:00:00 提供 Nasdaq GlobeNewswire
-
Lexeo Therapeutics Appoints Tim Van Hauwermeiren to its Board of Directors
08 7 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Lexeo Therapeutics Reports First Quarter 2024 Financial Results and Operational Highlights
09 5 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Lexeo Therapeutics to Participate in Upcoming Investor Conferences
07 5 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
22 4 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
16 4 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
Lexeo Therapeutics Announces Closing of Oversubscribed $95.0 Million Equity Financing
13 3 2024 16:22:39 提供 Nasdaq GlobeNewswire
-
11 3 2024 07:42:39 提供 Nasdaq GlobeNewswire
-
Lexeo Therapeutics Announces Oversubscribed $95.0 Million Equity Financing
11 3 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
Lexeo Therapeutics Strengthens Clinical Development Leadership with New Executive Appointments
05 2 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Lexeo Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
03 1 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
18 12 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Lexeo Therapeutics Reports Third Quarter 2023 Financial Results and Operational Highlights
11 12 2023 07:00:00 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >